Ameritas Investment Partners, Inc. Aerie Pharmaceuticals Inc Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $3,962 - $9,473	622 Added 20.03%	3,728 $56,000
Q1 2021 May 14, 2021	SELL	$13.12 - $20.9 $6,560 - $10,450	-500 Reduced 13.87%	3,106 $56,000
Q2 2019 Aug 14, 2019	BUY	$28.97 - $48.21 $18,598 - $30,950	642 Added 21.66%	3,606 $107,000
Q2 2018 Aug 13, 2018	BUY	$47.85 - $70.45 $7,608 - $11,201	159 Added 5.67%	2,964 $200,000
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $7,119 - $9,114	140 Added 5.25%	2,805 $168,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,665	2,665 $140,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.